HealthEquity Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

HealthEquity, Inc. HQY is set to release earnings results for its first quarter, after the closing bell on Jun 3.

Analysts expect the Draper, Utah-based company to report quarterly earnings at 66 cents per share, up from 50 cents per share in the year-ago period. HealthEquity is projected to report quarterly revenue of $278.11 million, according to data from Benzinga Pro.

On May 11, HealthEquity closed the acquisition of BenefitWallet HSA portfolio.

HealthEquity shares gained 3.2% to close at $81.68 on Friday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

• Barrington Research analyst Alexander Paris maintained an Outperform rating with a price target of $100 on March 22. This analyst has an accuracy rate of 82%.
• Raymond James analyst C. Gregory Peters maintained an Outperform rating and raised the price target from $90 to $95 on Dec. 13, 2023. This analyst has an accuracy rate of 76%.
• Baird analyst Mark Marcon upgraded the stock from Neutral to Outperform and increased the price target from $79 to $87 on Sept. 21, 2023. This analyst has an accuracy rate of 70%.
• Deutsche Bank analyst George Hill maintained a Buy rating and raised the price target from $71 to $72 on Sept. 7, 2023. This analyst has an accuracy rate of 62%.

Read This Next: Jim Cramer: Beyond Meat Is ‘Way Too Risky,’ Warby Parker Is ‘Alright To Buy‘